Exploiting dendritic cells in the development of cancer vaccines (Q38148774)

29 August 2017

Exploiting dendritic cells in the development of cancer vaccines (English)

1 reference

29 August 2017

1 reference

Federica Moschella

3

0 references

Laura Bracci

object named as

Laura Bracci

1

0 references

Enrico Proietti

object named as

Enrico Proietti

4

0 references

Filippo Belardelli

object named as

Filippo Belardelli

5

0 references

author name string

Imerio Capone

2

1 reference

PubMed ID

24090117

29 August 2017

language of work or name

1 reference

4 October 2013

1 reference

Expert Review of Vaccines

29 August 2017

1 reference

29 August 2017

12

1 reference

29 August 2017

10

1 reference

29 August 2017

1195-1210

1 reference

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

29 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Human dendritic cells. Enrichment and characterization from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Harnessing human dendritic cell subsets for medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Migration of dendritic cell subsets and their precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Steady-state and inflammatory dendritic-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cell biology of antigen processing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cutaneous dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Distinctive localization of antigen-presenting cells in human lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Targeting human dendritic cell subsets for improved vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Immunogenic and tolerogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic cells in vaccination therapies of human malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Current approaches in dendritic cell generation and future implications for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Fast dendritic cells stimulated with alternative maturation mixtures induce polyfunctional and long-lasting activation of innate and adaptive effector cells with tumor-killing capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Interferon-α-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Targeting dendritic cells--why bother?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Nanobody; an old concept and new vehicle for immunotargeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Trial watch: Dendritic cell-based interventions for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Clinical considerations in developing dendritic cell vaccine based immunotherapy protocols in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Current status and future applications of cellular therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

The secret ally: immunostimulation by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

More than just tumor destruction: immunomodulation by thermal ablation of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

T-regulatory cell modulation: the future of cancer immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Delayed-type hypersensitivity (DTH) immune response related with EBV-DNA in nasopharyngeal carcinoma treated with autologous dendritic cell vaccination after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Complete remission following decitabine/dendritic cell vaccine for relapsed neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Preoperative Mobilization of Circulating Dendritic Cells by Flt3 Ligand Administration to Patients With Metastatic Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

Dendritic Cell-Based Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.836905

10.1586/14760584.2013.836905

21 January 2018

Identifiers

DOI

1 reference

release_nzqxajfnkrfdlbm2j7auqbdyva

29 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nzqxajfnkrfdlbm2j7auqbdyva

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24090117

1 reference

PubMed ID

24090117